Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.153ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.153SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.153SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.153EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.153NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.153NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.302ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.302ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.302SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.302SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.302EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.302NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.302NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.194ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.194ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.194SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.194SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.194EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.194EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.194NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.194NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.55ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.177.55ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.177.55SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.177.55SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.177.55EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.51ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.51ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.51SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.51SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.51EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.308ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.308ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.308SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.308SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.308EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.308NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.308NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.138ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.138ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.138SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used